Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Blood (2019) 134 (Supplement_1): 494.

https://doi.org/10.1182/blood-2019-123674

Published: 2019

Journal Articles

Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia

Radhika Gangaraju, MD, Smita Bhatia, MDMPH, Kelly Kenzik, PhD

Blood (2019) 134 (Supplement_1): 4679.

https://doi.org/10.1182/blood-2019-124464

Published: 2019

Journal Articles

Laminin G Domains of Protein S Bind and Inhibit Fixa

Sabyasachi Chatterjee, PhD MSc, BSc, Amber Sylvain, Undergraduate Student, Satish Pilli, PhD, Whitney Fant, MS, Doerte R. Fricke, MS, Terry Watt, PhD, Rinku Majumder, PhD

Blood (2019) 134 (Supplement_1): 3624.

https://doi.org/10.1182/blood-2019-127112

Published: 2019

Journal Articles

Single Center Retrospective Study of Essential Thrombocythaemia Diagnosed Patients Treated with Interferon - Benefit and Tolerability

Joana Desterro, Donal P McLornan, MD PhD FRCP FRCPath, Natalia Curto-Garcia, Jennifer O'Sullivan, Kordasti Shahram, Claire Woodley, Yvonne Francis, Deepti Radia, MD, Claire N. Harrison, MD DM, FRCP, PRCPath

Blood (2018) 132 (Supplement 1): 5458.

https://doi.org/10.1182/blood-2018-99-115021

Published: 2018

Journal Articles

Determination of the Structural Changes Accompanying Binding of Protein S to Factor IX a

Sabyasachi Chatterjee, PhD MSc, BSc, Jessie J. Guidry, BS, William E Plautz, BS, Terry Watt, PhD, Rinku Majumder, PhD

Blood (2018) 132 (Supplement 1): 20.

https://doi.org/10.1182/blood-2018-99-118843

Published: 2018

Journal Articles

Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment

Sven Borchmann, MD, Ida Hude, MD, Horst Müller, PhD, Heinz Haverkamp, Carolin Bürkle, MD, Michael Fuchs, MD, Peter Borchmann, MD, Andreas Engert, MD

Blood (2016) 128 (22): 4151.

https://doi.org/10.1182/blood.V128.22.4151.4151

Published: 2016

Journal Articles

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John Grainger, James B. Bussel, MD, Nichola Cooper, Michael Tarantino, Victor Blanchette, Jenny Despotovic, Alexey Maschan, MD PhD, Nancy Carpenter, Melissa Eisen, Bhakti Mehta

Blood (2016) 128 (22): 869.

https://doi.org/10.1182/blood.V128.22.869.869

Published: 2016

Journal Articles

Central Venous Access Device (CVAD) Use and Complications in Sickle Cell Disease Patients from Medicaid and Commercially-Insured U.S. Populations

Nancy Maserejian, ScD, Cortney Hayflinger, MS, Susan Eaton, MSPH, Catherine Madigan, MD, William E. Hobbs, MDPhD

Blood (2015) 126 (23): 2057.

https://doi.org/10.1182/blood.V126.23.2057.2057

Published: 2015

Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone Is Well Tolerated in Patients with Relapsed/Refractory Multiple Myeloma Who Have Received One Prior Regimen

Kwee L Yong, MBChB, PhD, Sarah Brown, Samantha Hinsley, Louise Flanagan, Neil Rabin, MB,BS, PhD, Karthik Ramasamy, Jamie Cavenagh, Roger G Owen, Martin F Kaiser, MD, Eric Low, Catherine Williams

Blood (2015) 126 (23): 1840.

https://doi.org/10.1182/blood.V126.23.1840.1840

Published: 2015

Journal Articles

The Use of Temporary Central Venous Catheters for Optimizing Continuous Infusion in Hemophilia Patients Undergoing Major Surgical Procedures

Ana Boban, MD PhD, Catherine M Lambert, MD, Cedric R. Hermans, MD PhD

Blood (2014) 124 (21): 2822.

https://doi.org/10.1182/blood.V124.21.2822.2822

Published: 2014

Journal Articles

Venous Thromboembolism Prophylaxis with Aspirin for Multiple Myeloma Patients Receiving Thalidomide Combination As First-Line Treatment

Edvan de Queiroz Crusoe, MD MsC, Mariana Massarenti, MD, Manuella Almeida, MDPhD, Priscilla Cury, MD, Fabiana Higashi, MD, Luiza Vieira, MD, Marina Rossato, MD, Ana Lucia Peres, MD, Anna Carolina Castro, MD, Ana Luiza Silva, MD, Vania T M Hungria, MDPhD

Blood (2014) 124 (21): 5764.

https://doi.org/10.1182/blood.V124.21.5764.5764

Published: 2014

Journal Articles

Peripherally Inserted Central Catheters Are a Good Option For Venous Access In The Patients With Hematologic Diseases

Naoko Takaiwa, MD, Masanori Seki, MD, PhD, Naoki Kurita, MD, PhD, Yasuhisa Yokoyama, MD, PhD, Mamiko Sakata-Yanagimoto, MD, PhD, Naoshi Obara, MD, PhD, Kazumi Suzukawa, MD, PhD, Yuichi Hasegawa, MD, PhD, Shigeru Chiba, MD, PhD

Blood (2013) 122 (21): 2956.

https://doi.org/10.1182/blood.V122.21.2956.2956

Published: 2013

Journal Articles

Periodic Evaluation Of The Clone Size Is Mandatory In PNH: Study Of The Spanish Cohort Of The International PNH Registry

Ana Villegas, Ana Gaya, Emilio Ojeda, MD, PhD, Ataulfo Gonzalez, Alvaro Urbano, MD, Isabel Gomez Roncero, Maria Victoria Cuevas, Raul Cordoba, Isidro Jarque, MD, Ramiro NuÃ±ez, Beatriz Arrizabalaga, MD

Blood (2013) 122 (21): 3715.

https://doi.org/10.1182/blood.V122.21.3715.3715

Published: 2013

Journal Articles

Is Deep-Vein Thrombosis Always the Origin of Pulmonary Embolism? Imaging of Veins with a Total-Body Direct Thrombus MRI Technique

Kirsten van Langevelde, MD, Alexandr Srámek, MD, PhD, Patrice W.J. Vincken, MD, PhD, Jan-Kees van Rooden, MD, PhD, Frits R. Rosendaal, PhD, Suzanne C. Cannegieter, MD, PhD

Blood (2011) 118 (21): 2297.

https://doi.org/10.1182/blood.V118.21.2297.2297

Published: 2011

Journal Articles

Cancer-Associated Thrombosis: Cancer Cell-Derived Microparticles As a Trigger of Venous Thrombosis in a Mouse Model of Flow Restriction

Grace M. Thomas, PhD, Alexander Brill, MD, PhD, Denisa D. Wagner, PhD

Blood (2011) 118 (21): 34.

https://doi.org/10.1182/blood.V118.21.34.34

Published: 2011

Journal Articles

Clinical Characteristics of Classic Paroxysmal Nocturnal Hemoglobinuria (PNH) in Pediatric Patients: A Comparison with Classic PNH in Adults. An International PNH Registry Study

Alvaro Urbano-Ispizua, MD, Hubert Schrezenmeier, MD, Petra Muus, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, Gérard Socié, Jeffrey Szer, MBBS, FRACP, Robert A. Brodsky, MD, Monica Bessler, MD, PhD, Wendell F Rosse, MD, Yuzuru Kanakura, Gus Khursigara, PhD, Camille L Bedrosian, MD, Peter Hillmen, MBChB, PhD

Blood (2011) 118 (21): 2102.

https://doi.org/10.1182/blood.V118.21.2102.2102

Published: 2011

Journal Articles

Circulating Nucleosomes Reflect Disease Activity in Patients with Thrombotic Microangiopathies.

Tobias A. Fuchs, PhD, Johanna A. Kremer Hovinga, MD, Daphne Schatzberg, BS, Marc Monestier, MD, PhD, Denisa D. Wagner, PhD, Bernhard Lämmle, MD

Blood (2010) 116 (21): 1437.

https://doi.org/10.1182/blood.V116.21.1437.1437

Published: 2010

Journal Articles

Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.

Leonard A. Valentino, MD, FAAP, David L. Cooper, MD, MBA

Blood (2009) 114 (22): 1304.

https://doi.org/10.1182/blood.V114.22.1304.1304

Published: 2009

Journal Articles

A Low Wells Score in a Hospital Setting May No Longer Safely Rule out Deep Vein Thrombosis: Preliminary Results From a Single-Center Prospective University-Hospital Study Involving 227 Patients.

Ynse IGV Tichelaar, MD, Karina Meijer, MD, PhD, Jan ter Maaten, MD, PhD, Matthijs Oudkerk, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Willem M. Lijfering, MD, PhD

Blood (2009) 114 (22): 2469.

https://doi.org/10.1182/blood.V114.22.2469.2469

Published: 2009

Journal Articles

Correction of Anemia with Hematide™, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), in Oncology Patients Receiving Chemotherapy.

Lisa M. Pickering, MBBS, BA, MRCP, Karel Cwiertka, MD, Jacek Jassem, Jira Petera, MD, Ruth Pettengell, MBchB, FRACP, PhD, Rodryg Ramlau, MD, PhD, Jiri Vorlicek, Rostislav Vyzula, MD, Anne-Marie Duliege, MD, MS, William Lang, MD, Richard B. Stead, MD, Peter G. Harper, LRCP, MRCS, MBBS

Blood (2007) 110 (11): 3666.

https://doi.org/10.1182/blood.V110.11.3666.3666

Published: 2007

NARROW

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia

Laminin G Domains of Protein S Bind and Inhibit Fixa

Single Center Retrospective Study of Essential Thrombocythaemia Diagnosed Patients Treated with Interferon - Benefit and Tolerability

Determination of the Structural Changes Accompanying Binding of Protein S to Factor IX a

Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Central Venous Access Device (CVAD) Use and Complications in Sickle Cell Disease Patients from Medicaid and Commercially-Insured U.S. Populations

Carfilzomib, Cyclophosphamide and Dexamethasone Is Well Tolerated in Patients with Relapsed/Refractory Multiple Myeloma Who Have Received One Prior Regimen

The Use of Temporary Central Venous Catheters for Optimizing Continuous Infusion in Hemophilia Patients Undergoing Major Surgical Procedures

Venous Thromboembolism Prophylaxis with Aspirin for Multiple Myeloma Patients Receiving Thalidomide Combination As First-Line Treatment

Peripherally Inserted Central Catheters Are a Good Option For Venous Access In The Patients With Hematologic Diseases

Periodic Evaluation Of The Clone Size Is Mandatory In PNH: Study Of The Spanish Cohort Of The International PNH Registry

Is Deep-Vein Thrombosis Always the Origin of Pulmonary Embolism? Imaging of Veins with a Total-Body Direct Thrombus MRI Technique

Cancer-Associated Thrombosis: Cancer Cell-Derived Microparticles As a Trigger of Venous Thrombosis in a Mouse Model of Flow Restriction

Clinical Characteristics of Classic Paroxysmal Nocturnal Hemoglobinuria (PNH) in Pediatric Patients: A Comparison with Classic PNH in Adults. An International PNH Registry Study

Circulating Nucleosomes Reflect Disease Activity in Patients with Thrombotic Microangiopathies.

Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.

A Low Wells Score in a Hospital Setting May No Longer Safely Rule out Deep Vein Thrombosis: Preliminary Results From a Single-Center Prospective University-Hospital Study Involving 227 Patients.

Correction of Anemia with Hematide™, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), in Oncology Patients Receiving Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only